Andersen P - Search Results

1

Antiviral Innate Immune Activation in HIV-Infected Adults Negatively Affects H1/IC31-Induced Vaccine-Specific Memory CD4+ T Cells.

Lenz N, Schindler T, Kagina BM, Zhang JD, Lukindo T, Mpina M, Bang P, Kromann I, Hoff ST, Andersen P, Reither K, Churchyard GJ, Certa U, Daubenberger CA. Lenz N, et al. Among authors: andersen p. Clin Vaccine Immunol. 2015 Jul;22(7):688-96. doi: 10.1128/CVI.00092-15. Epub 2015 Apr 29. Clin Vaccine Immunol. 2015. PMID: 25924764 Free PMC article. Clinical Trial.

2

Specificity of a protective memory immune response against Mycobacterium tuberculosis.

Andersen P, Heron I. Andersen P, et al. Infect Immun. 1993 Mar;61(3):844-51. doi: 10.1128/iai.61.3.844-851.1993. Infect Immun. 1993. PMID: 8432604 Free PMC article.

3

Analysis of T cells recruited during delayed-type hypersensitivity to purified protein derivative (PPD) versus challenge with tuberculosis infection.

Pais TF, Silva RA, Smedegaard B, Appelberg R, Andersen P. Pais TF, et al. Among authors: andersen p. Immunology. 1998 Sep;95(1):69-75. doi: 10.1046/j.1365-2567.1998.00561.x. Immunology. 1998. PMID: 9767459 Free PMC article.

4

CD4(+) T-cell subsets that mediate immunological memory to Mycobacterium tuberculosis infection in mice.

Andersen P, Smedegaard B. Andersen P, et al. Infect Immun. 2000 Feb;68(2):621-9. doi: 10.1128/IAI.68.2.621-629.2000. Infect Immun. 2000. PMID: 10639425 Free PMC article.

5

Control of latent Mycobacterium tuberculosis infection is dependent on CD8 T cells.

van Pinxteren LA, Cassidy JP, Smedegaard BH, Agger EM, Andersen P. van Pinxteren LA, et al. Among authors: andersen p. Eur J Immunol. 2000 Dec;30(12):3689-98. doi: 10.1002/1521-4141(200012)30:12<3689::AID-IMMU3689>3.0.CO;2-4. Eur J Immunol. 2000. PMID: 11169412 Free article.

6

Tuberculosis subunit vaccine development: on the role of interferon-gamma.

Agger EM, Andersen P. Agger EM, et al. Among authors: andersen p. Vaccine. 2001 Mar 21;19(17-19):2298-302. doi: 10.1016/s0264-410x(00)00519-3. Vaccine. 2001. PMID: 11257351

7

A novel TB vaccine; towards a strategy based on our understanding of BCG failure.

Agger EM, Andersen P. Agger EM, et al. Among authors: andersen p. Vaccine. 2002 Nov 22;21(1-2):7-14. doi: 10.1016/s0264-410x(02)00447-4. Vaccine. 2002. PMID: 12443657 Review.

8

A novel TB vaccine; strategies to combat a complex pathogen.

Olsen AW, Andersen P. Olsen AW, et al. Among authors: andersen p. Immunol Lett. 2003 Jan 22;85(2):207-11. doi: 10.1016/s0165-2478(02)00232-8. Immunol Lett. 2003. PMID: 12527229 Review.

9

Protective immunity to tuberculosis with Ag85B-ESAT-6 in a synthetic cationic adjuvant system IC31.

Agger EM, Rosenkrands I, Olsen AW, Hatch G, Williams A, Kritsch C, Lingnau K, von Gabain A, Andersen CS, Korsholm KS, Andersen P. Agger EM, et al. Among authors: andersen cs, andersen p. Vaccine. 2006 Jun 29;24(26):5452-60. doi: 10.1016/j.vaccine.2006.03.072. Epub 2006 Apr 17. Vaccine. 2006. PMID: 16675077

10

TB vaccine strategies--what is needed to solve a complex problem?

Dietrich J, Lundberg CV, Andersen P. Dietrich J, et al. Among authors: andersen p. Tuberculosis (Edinb). 2006 May-Jul;86(3-4):163-8. doi: 10.1016/j.tube.2006.01.009. Tuberculosis (Edinb). 2006. PMID: 16678489 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,103 results

Search Page

Filters